GlassesOff, Inc. (OTC: GLSO): Can Digital Neuroscience Transform Vision Care?
Investment Research Overview GlassesOff, Inc. (OTC: GLSO) represents a unique chapter in the digital health sector. Unlike many micro-cap biotechnology companies pursuing pharmaceutical treatments, GlassesOff focused on software-based vision improvement through neuroscience. Its flagship product, the GlassesOff mobile application, was designed to improve near vision by training the brain's visual processing system rather than altering the physical characteristics of the eye. While the company attracted significant attention during the early wave of digital therapeutics, investors should recognize that GlassesOff today differs substantially from the growth story originally presented to public markets. Much of the company's technology remains scientifically interesting, but its commercial activity appears to have slowed dramatically over recent years. Company Background GlassesOff traces its origins to Israel, where [...]
